Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery

European Journal of Ophthalmology

Volumn 15, Issue 1, 2005, Pages 158-161

  Altintaş, Özgül ^a,b   Yuksel N ^a   Karabas V L ^a   Demirci, G ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b Yavuz Sultan Mahallesi   (Turkey)

Author keywords

Cystoid macular edema; Latanoprost; Pseudophakia; Uncomplicated

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ANTIINFLAMMATORY AGENT; CIPROFLOXACIN; DORZOLAMIDE; KETOROLAC; LATANOPROST; PREDNISOLONE ACETATE; PROSTAGLANDIN DERIVATIVE; TIMOLOL; ANTIHYPERTENSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN F;

ADULT; AGED; CASE REPORT; CATARACT; CATARACT EXTRACTION; FEMALE; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA; HUMAN; LENS IMPLANT; MALE; PHACOEMULSIFICATION; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; REVIEW; VISUAL ACUITY; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG EFFECT; EXFOLIATION SYNDROME; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MIDDLE AGED; PSEUDOPHAKIA; RETROSPECTIVE STUDY;

ACETAZOLAMIDE; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; EXFOLIATION SYNDROME; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LENS IMPLANTATION, INTRAOCULAR; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PHACOEMULSIFICATION; PROSTAGLANDINS F, SYNTHETIC; PSEUDOPHAKIA; RETROSPECTIVE STUDIES;

EID: 15544371468     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500128     Document Type: Review

References (23)

1. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveascleral outflow. Surv Ophthalmol 1997; 41(Suppl): S53-9.
2. Toris CB, Camras CB, Yablonski ME. Effects of PhXA41, a new prostaglandin F2a analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993; 100: 1297-304.
3. Nilsson SFE, Samuelsson M, Bill A, Stjernschantz J. Increased uveascleral outflow as a possible mechanism of ocular hypertension caused by prostaglandin F2a-1-isopropylester in the cynomolgus monkey. Exp Eye Res 1989; 48: 707-16.
4. Gabelt BT, Kaufman PL. Prostaglandin F2a increase uveascleral outflow in the cynomolgus monkey. Exp Eye Res 1989; 49: 389-402.
5. Miyake K, Ota I, Maekubo K, lchihashi S, Miyake S. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol 1999; 117: 34-40.
6. Rowe JA, Hattenhauer MG, Herman DC. Adverse side effects associated with latanoprost. Am J Ophthalmol 1997; 124: 683-5.
7. Warmar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use; experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998; 105: 263-8.
8. Avakian A, Anderson Renier S, Butler PJ. Adverse effects of latanoprost on patients with medically resistant glaucoma. Arch Ophthalmol 1998; 116: 679-80.
9. Heier JS, Steinert RF, Frederick AR Jr. Cystoid macular edema associated with latanoprost use. Arch Ophthalmol 1998; 116: 680-2.
10. Callanan D, Fellman RL, Savage JA. Latanoprost associated cystoid macular edema. Am J Ophthalmol 1998; 126: 134-5.
11. Ayyala RS, Cruz DA, Margo CE, et al. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol 1998; 126: 602-4.
12. Moroi SE, Gottfredsdottir MS, Schteingart MT, et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 1999; 106: 1024-9.
13. Schumer RA, Camras CB, Mandahl AK. Latanoprost and cystoid macular edema: is there a causal relation? Curr Opin Ophthalmol 2000; 11: 94-100.
14. Wand M, Gaudio A, Shields B. Latanoprost and cystoid macular edema in high-risk aphakic or pseudophakic eyes. J Cataract Refract Surg 2001; 27: 1397-401.
15. Tokunaga T, Kashiwagi K, Saito J, et al. A case of cystoid macular edema associated with latanoprost ophthalmic solution. Jpn J Ophthalmol 2002; 46: 656-9.
16. Watanabe K, Hayasaka S, Hayasaka Y, Nagaki Y, Watanabe K. Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications. Jpn J Ophthalmol 2003; 47: 110-2.
17. Jäger M, Jonas JB. Cystoid macular edema associated with latanoprost therapy in a pseudophakic vitrectomized patient after removal of silicone oil endotamponade. Eur J Ophthalmol 2003; 13: 221-3.
18. Yeh PC, Ramanathan S. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. J Cataract Refract Surg 2002; 28: 1814-8.
19. Miyake K, Ota I, Ibaraki N, et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 2001; 119: 387-94.
20. Kolker AE, Becker B. Epinephrine maculopathy. Arch Ophthalmol 1968; 79: 552-62.
21. Michels RG, Maumenee AE. Cystoid macular edema associated with topically applied epinephrine in aphakic eyes. Am J Ophthalmol 1975; 80: 379-88.
22. Miyake K, Nobuhiro I. Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002; 47 (Suppl): S203-18.
23. Küchle M, Nguyen N, Hannappel E. The blood-aqueous barrier in eyes with pseudoexfoliation syndrome. Ophthalmic Res 1995; 27 (Suppl): S136-42.